BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $83,177,094 | -46.9% | 1,099,328 | +2.2% | 0.06% | -42.6% |
| Q2 2022 | $156,709,000 | -51.2% | 1,075,466 | -60.3% | 0.11% | -30.3% |
| Q1 2022 | $320,892,000 | +65.5% | 2,706,152 | +92.4% | 0.16% | +91.4% |
| Q4 2021 | $193,840,000 | +82.3% | 1,406,555 | +83.8% | 0.08% | +76.1% |
| Q3 2021 | $106,313,000 | +48.4% | 765,375 | +3.7% | 0.05% | +48.4% |
| Q2 2021 | $71,631,000 | +45.9% | 737,895 | +2.8% | 0.03% | +40.9% |
| Q1 2021 | $49,082,000 | -23.8% | 718,040 | -42.6% | 0.02% | -38.9% |
| Q1 2019 | $64,420,000 | -44.6% | 1,251,607 | -60.2% | 0.04% | -51.4% |
| Q4 2018 | $116,256,000 | -7.2% | 3,143,758 | -5.8% | 0.07% | +10.4% |
| Q3 2018 | $125,301,000 | -3.9% | 3,336,916 | +1.1% | 0.07% | -9.5% |
| Q2 2018 | $130,388,000 | +49.0% | 3,299,300 | -2.9% | 0.07% | +42.3% |
| Q1 2018 | $87,484,000 | +230.8% | 3,396,130 | +246.5% | 0.05% | +225.0% |
| Q4 2017 | $26,443,000 | +2.7% | 980,109 | +42.3% | 0.02% | -5.9% |
| Q3 2017 | $25,751,000 | +59.5% | 688,909 | +6.7% | 0.02% | +54.5% |
| Q2 2017 | $16,144,000 | – | 645,743 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |